Literature DB >> 21420225

Salting-in characteristics of globular proteins.

Ronald W Maurer1, Stanley I Sandler, Abraham M Lenhoff.   

Abstract

Protein solubility, and the formation of various solid phases, is of interest in both bioprocessing and the study of protein condensation diseases. Here we examine the the phase behavior of three proteins (chymosin B, β-lactoglobulin B, and pumpkin seed globulin) previously known to display salting-in behavior, and measure their solubility as a function of pH, ionic strength, and salt type. Although the phase behavior of the three proteins is quantitatively different, general trends emerge. Stable crystal nucleation does not occur within the salting-in region for the proteins examined, despite the crystal being observed as the most stable solid phase. Instead, two types of amorphous phases were found within the salting-in region; additionally, an analog to the instantaneous clouding curve was observed within the salting-in region for chymosin B. Also, protein solutions containing sulfate salts resulted in different crystal morphologies depending on whether Li(2)SO(4) or (NH(4))(2)SO(4) was used.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21420225     DOI: 10.1016/j.bpc.2011.02.002

Source DB:  PubMed          Journal:  Biophys Chem        ISSN: 0301-4622            Impact factor:   2.352


  3 in total

Review 1.  Structure, heterogeneity and developability assessment of therapeutic antibodies.

Authors:  Yingda Xu; Dongdong Wang; Bruce Mason; Tony Rossomando; Ning Li; Dingjiang Liu; Jason K Cheung; Wei Xu; Smita Raghava; Amit Katiyar; Christine Nowak; Tao Xiang; Diane D Dong; Joanne Sun; Alain Beck; Hongcheng Liu
Journal:  MAbs       Date:  2018-12-17       Impact factor: 5.857

2.  Ion Specificity and Nonmonotonic Protein Solubility from Salt Entropy.

Authors:  Yuba Raj Dahal; Jeremy D Schmit
Journal:  Biophys J       Date:  2018-01-09       Impact factor: 4.033

3.  Defining the right diluent for intravenous infusion of therapeutic antibodies.

Authors:  Shen Luo; Keisha Melodi McSweeney; Tao Wang; Silvia M Bacot; Gerald M Feldman; Baolin Zhang
Journal:  MAbs       Date:  2020 Jan-Dec       Impact factor: 5.857

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.